Covid-19: Mumbai firm seeks regulator nod for ARV trials ...Middle East

The Times of India - News
Covid-19: Mumbai firm seeks regulator nod for ARV trials
In an indication of innovation in pharmaceuticals for Covid-19, Mumbai-based Glenmark may become the first company in India to offer an anti-retroviral, a class of drugs which has shown promise, and is being used as a potential treatment for the virus. Glenmark has developed anti-retroviral (ARV) drug Favipiravir, which has shown positive results globally, and has applied for regulatory approval for trials in India, sources told TOI.

Hence then, the article about covid 19 mumbai firm seeks regulator nod for arv trials was published today ( ) and is available on The Times of India ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Covid-19: Mumbai firm seeks regulator nod for ARV trials )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News